Persisting psychotic states in adolescent drug users.
D000293:Adolescent; D002385:Cataplexy / Q000139:chemically induced; D002674:Child, Institutionalized; D002746:Chlorpromazine / Q000627:therapeutic use; D003702:Delusions / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006213:Hallucinogens / Q000378:metabolism; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010551:Personality; D011605:Psychoses, Substance-Induced / Q000188:drug therapy / Q000209:etiology*; D019966:Substance-Related Disorders / Q000150:complications*; D013572:Synaptic Vesicles / Q000378:metabolism; D013881:Thioridazine / Q000627:therapeutic use; D013888:Thiothixene / Q000627:therapeutic use; D013997:Time Factors; D014268:Trifluoperazine / Q000627:therapeutic use; D014474:Unconsciousness / Q000139:chemically induced; D014754:Violence
D006213:Hallucinogens; D014268:Trifluoperazine; D013888:Thiothixene; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine